As of 2025-07-21, the Relative Valuation of Jenburkt Pharmaceuticals Ltd (524731.BO) is 1,617.15 INR. This relative valuation is based on P/E multiples. With the latest stock price at 1,306.00 INR, the upside of Jenburkt Pharmaceuticals Ltd based on Relative Valuation is 23.8%.
The range of the Relative Valuation is 1,290.84 - 2,217.34 INR.
| Range | Selected | |
| Trailing P/E multiples | 20.7x - 30.5x | 26.4x |
| Forward P/E multiples | 16.5x - 20.0x | 16.8x |
| Fair Price | 1,290.84 - 2,217.34 | 1,617.15 |
| Upside | -1.2% - 69.8% | 23.8% |
| Date | P/E |
| 2025-07-17 | 17.96 |
| 2025-07-16 | 17.73 |
| 2025-07-15 | 17.88 |
| 2025-07-14 | 18.53 |
| 2025-07-11 | 18.49 |
| 2025-07-10 | 19.08 |
| 2025-07-09 | 18.87 |
| 2025-07-08 | 18.74 |
| 2025-07-07 | 19.16 |
| 2025-07-04 | 19.10 |
| 2025-07-03 | 18.38 |
| 2025-07-02 | 19.17 |
| 2025-07-01 | 18.57 |
| 2025-06-30 | 18.88 |
| 2025-06-27 | 18.02 |
| 2025-06-26 | 17.95 |
| 2025-06-25 | 17.91 |
| 2025-06-24 | 17.87 |
| 2025-06-23 | 17.88 |
| 2025-06-20 | 18.02 |
| 2025-06-19 | 17.47 |
| 2025-06-18 | 18.38 |
| 2025-06-17 | 18.43 |
| 2025-06-16 | 18.12 |
| 2025-06-13 | 18.21 |
| 2025-06-12 | 17.88 |
| 2025-06-11 | 17.47 |
| 2025-06-10 | 17.33 |
| 2025-06-09 | 17.85 |
| 2025-06-06 | 17.94 |
| 2025-06-05 | 17.99 |
| 2025-06-04 | 17.85 |
| 2025-06-03 | 15.89 |
| 2025-06-02 | 15.75 |
| 2025-05-30 | 15.63 |
| 2025-05-29 | 15.93 |
| 2025-05-28 | 16.05 |
| 2025-05-27 | 16.27 |
| 2025-05-26 | 16.30 |
| 2025-05-23 | 16.27 |
| 2025-05-22 | 16.04 |
| 2025-05-21 | 15.93 |
| 2025-05-20 | 15.54 |
| 2025-05-19 | 15.35 |
| 2025-05-16 | 15.09 |
| 2025-05-15 | 14.44 |
| 2025-05-14 | 14.10 |
| 2025-05-13 | 14.22 |
| 2025-05-12 | 14.29 |
| 2025-05-09 | 13.76 |